Cyprus clears cannabinoids for medical use – report

A North American-based company specialising in medical cannabis research and production, announced on Thursday that it was cleared for distribution of cannabinoid formulations for patients in Cyprus. According to an announcement on BusinessWire, the company, Tilray, said its cannabinoid products have cleared for distribution in Cyprus after it had received necessary approvals in Canada and Cyprus.

Read more in Cyprus Mail Online